Last year fundamentally challenged the way we think about global health. Now, meaningful reform must include strengthening the conditions for medical breakthroughs and ensuring that medicines and vaccines reach people faster and more efficiently.
Public debate on the effectiveness of multilateralism, conflict and fiscal challenges, and the emergence of a new geopolitical reality has led some to question whether global cooperation on health is weakening.
At the same time, there is a growing consensus that we could be presented with a rare moment to reshape the global health architecture in a way that better supports countries to prioritize and invest in strong healthcare systems.
Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
About the author
David Reddy
David Reddy is the director general of IFPMA, representing the innovative pharmaceutical industry globally and in official relations with the United Nations. With over three decades in global health and pharmaceuticals, he brings experience spanning R&D, product commercialization and access, policy and advocacy, partnerships, and organizational leadership across private and nonprofit sectors.
